Showing 1 - 2 results of 2 for search 'Ryutaro Shimazaki', query time: 0.02s Refine Results
  1. 1
    Phase 2b study of evocalcet (KHK7580), a novel calcimimetic, in Japanese patients with secondary hyperparathyroidism undergoing hemodialysis: A randomized, double-blind, placebo-controlled, dose-finding study.

    Phase 2b study of evocalcet (KHK7580), a novel calcimimetic, in Japanese patients with secondary hyperparathyroidism undergoing hemodialysis: A randomized, double-blind, placebo-co... by Tadao Akizawa, Ryutaro Shimazaki, Masafumi Fukagawa, Evocalcet Study Group

    Published 2018-01-01
    Get full text
    Article
  2. 2
    Long-Term Efficacy and Safety of Evocalcet in Japanese Patients with Secondary Hyperparathyroidism Receiving Hemodialysis

    Long-Term Efficacy and Safety of Evocalcet in Japanese Patients with Secondary Hyperparathyroidism Receiving Hemodialysis by Keitaro Yokoyama, Ryutaro Shimazaki, Masafumi Fukagawa, Tadao Akizawa, On behalf of Evocalcet Study Group

    Published 2019-04-01
    Get full text
    Article

Search Tools: